+ All Categories
Home > Documents >  · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a...

 · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a...

Date post: 14-Oct-2020
Category:
Upload: others
View: 7 times
Download: 0 times
Share this document with a friend
4
Transcript
Page 1:  · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a non-NMDA receptor antagonist) into the nucleus prepositus hypo- glossi (NPH) of the
Page 2:  · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a non-NMDA receptor antagonist) into the nucleus prepositus hypo- glossi (NPH) of the
Page 3:  · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a non-NMDA receptor antagonist) into the nucleus prepositus hypo- glossi (NPH) of the
Page 4:  · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a non-NMDA receptor antagonist) into the nucleus prepositus hypo- glossi (NPH) of the

Recommended